Biofrontera Inc. to Report Third Quarter 2023 Financial Results on November 9 and Hold Conference Call on November 10

WOBURN, MA / ACCESSWIRE / November 3, 2023 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the three and nine months ended September 30, 2023, after the close of the U.S. financial markets on Thursday, November 9, 2023. The Company will hold a conference call on Friday, November 10, 2023 beginning at 10:00 a.m. Eastern time to discuss those results, provide a business update and answer questions.

Conference Call and Webcast Information

Event: Biofrontera Inc. Third Quarter 2023 Financial Results and Business Update Conference Call
Date: Friday, November 10, 2023
Time: 10:00 a.m. Eastern time
Conference call:

1-877-877-1275 (U.S.)

1-412-858-5202 (international)

Webcast: Live and 90-day replay webcast are available here and at investors.biofrontera-us.com.

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of products for the treatment of dermatologic conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.

Contact:

LHA Investor Relations
Tirth T. Patel
212-201-6614
tpatel@lhai.com

SOURCE: Biofrontera Inc.

View source version on accesswire.com:
https://www.accesswire.com/799091/biofrontera-inc-to-report-third-quarter-2023-financial-results-on-november-9-and-hold-conference-call-on-november-10

Staff

Recent Posts

Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock

PALO ALTO, Calif., Dec. 16, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial…

30 minutes ago

Nested Knowledge and Pharmacy Podcast Network Announce Strategic Collaboration to Advance Evidence-Based Podcasting in Healthcare

New partnership combines AI-powered evidence synthesis with trusted pharmacist-led audio content to elevate clinical education…

30 minutes ago

Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength

ST. PAUL, Minn., Dec. 16, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that it…

6 hours ago

2026 Brings Sharp 21% Spike in Health Insurance Premiums – Squeezing Household Budgets

ValuePenguin finds in 45 states, 2026 Health Insurance Premiums are Increasing by More Than 10%…

6 hours ago

Bioassay Method Transfer Strategies to Reduce Variability, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how to identify sources of variability in bioassay method transfers…

6 hours ago